Three gold indicators for breast cancer prognosis: a case–control study with ROC analysis for novel ratios related to CBC with (ALP and LDH)
- 24 Downloads
Science is still unable to develop a specific strategy for predicting breast cancer in humans. Several attempts are done to obtain the best and closest prognostic predictive biomarkers for breast cancer. The present study aimed to evaluate the impact of novel ratios calculated between the blood indices with CA15.3, alkaline phosphatase and lactate dehydrogenase as prognostic biomarkers in breast cancer. This study was conducted on two groups (Breast cancer Patients group in comparison to a control group who has no tumor family history). All the volunteers are subjected to the routine analysis included liver and kidney function tests, complete blood count with blood indices, tumor markers (CA15.3) assessment, alkaline phosphatase, and lactate dehydrogenase analysis. Thirty different ratios were calculated in the present research between blood indices and three inexpensive serum biomarkers; CA15.3, alkaline phosphatase and lactate dehydrogenase. Fifteen ratios of them were significant in breast cancer group than the control group. Three ratios (PDW/lymphocytes, MPV/lymphocytes, and ALP/RDW) of them gave a sensitivity of 100% with high specificity as indicators for breast cancer incidence. The correlation between significant ratios was very interesting. The more interesting was in the results of subgroup analysis which showed that the ALP/RDW ratio is more specific for pre-menopause while PDW/lymphocytes ratio is more specific for post-menopause. The ratios PDW/lymphocytes, MPV/lymphocytes, and ALP/RDW can be used as prognostic biomarkers in breast cancer patients. The interesting advantage in the results depends on the availability of these indicators in routine blood analysis and will not increase the cost of the diagnostic plan.
KeywordsBreast cancer Platelets distribution width Red cell distribution width Mean platelets volume Alkaline phosphatase Lactate dehydrogenase
We appreciate the collaboration of all participants and staff at Zagazig University Hospital, Egypt.
Compliance with ethical standards
Conflict of interest
The author declares no conflict of interests.
The study was approved by the Ethics Committee of the Zagazig University.
Written informed consent was obtained from all participants.
- 1.Wang H, Naghavi M, Allen C et al (2016) Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet 388:1459–1544. https://doi.org/10.1016/S0140-6736(16)31012-1 CrossRefGoogle Scholar
- 2.Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Allen C et al (2017) Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol 3:524–548. https://doi.org/10.1001/jamaoncol.2016.5688 CrossRefPubMedCentralGoogle Scholar
- 3.Silverstein A, Sood R, Costas-Chavarri A (2016) Breast Cancer in Africa: Limitations and Opportunities for Application of Genomic Medicine. Int J Breast Cancer. https://www.hindawi.com/journals/ijbc/2016/4792865/. Accessed 12 Dec 2018
- 16.Kaito K, Otsubo H, Usui N et al (2005) Platelet size deviation width, platelet large cell ratio, and mean platelet volume have sufficient sensitivity and specificity in the diagnosis of immune thrombocytopenia. Br J Haematol 128:698–702. https://doi.org/10.1111/j.1365-2141.2004.05357.x CrossRefPubMedGoogle Scholar
- 17.Zhang F, Chen Z, Wang P et al (2016) Combination of platelet count and mean platelet volume (COP-MPV) predicts postoperative prognosis in both resectable early and advanced stage esophageal squamous cell cancer patients. Tumor Biol 37:9323–9331. https://doi.org/10.1007/s13277-015-4774-3 CrossRefGoogle Scholar
- 51.Pelizzari G, Gerratana L, Basile D et al (2018) Prognostic role of alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) in metastatic breast cancer (MBC) patients: First clues for cost-effective biomarkers. J Clin Oncol 36:e13079–e13079. https://doi.org/10.1200/JCO.2018.36.15_suppl.e13079 CrossRefGoogle Scholar
- 67.Henry RJ, Chiamori N, Golub OJ, Berkman S (1960) Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol 34:381–398. https://doi.org/10.1093/ajcp/34.4_ts.381 CrossRefPubMedGoogle Scholar
- 68.Jia W, Wu J, Jia H et al (2015) The peripheral blood neutrophil-to-lymphocyte ratio is superior to the lymphocyte-to-monocyte ratio for predicting the long-term survival of triple-negative breast cancer patients. PLoS ONE 10:e0143061. https://doi.org/10.1371/journal.pone.0143061 CrossRefPubMedPubMedCentralGoogle Scholar
- 83.Han KS, Hong SJ (2014) Serum alkaline phosphatase differentiates prostate-specific antigen flare from early disease progression after docetaxel chemotherapy in castration-resistant prostate cancer with bone metastasis. J Cancer Res Clin Oncol 140:1769–1776. https://doi.org/10.1007/s00432-014-1710-7 CrossRefPubMedGoogle Scholar
- 90.Scartozzi M, Giampieri R, Maccaroni E et al (2012) Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. Br J Cancer 106:799–804. https://doi.org/10.1038/bjc.2012.17 CrossRefPubMedPubMedCentralGoogle Scholar
- 91.Brown JE, Cook RJ, Lipton A, Coleman RE (2012) Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients. Clin Cancer Res 18:6348–6355. https://doi.org/10.1158/1078-0432.CCR-12-1397 CrossRefGoogle Scholar
- 95.Kayacan O, Karnak D, Beder S et al (2006) Impact of TNF-α and IL-6 levels on development of cachexia in newly diagnosed NSCLC patients. Am J Clin Oncol 29:328–335. https://doi.org/10.1097/01.coc.0000221300.72657.e0 CrossRefPubMedGoogle Scholar
- 105.Riedl J, Posch F, Königsbrügge O et al (2014) Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality. PLoS ONE 9:e111440. https://doi.org/10.1371/journal.pone.0111440 CrossRefPubMedPubMedCentralGoogle Scholar